Simultaneous surgeries in bariatric surgery (literature review)

Cover Page

Cite item

Full Text

Abstract

Based on the available publications, the article presents an analysis of the studies on the simultaneous implementation of cholecystectomy, ventral and paraesophageal hernia repair during a bariatric intervention. If there is a clinical picture of chronic calculous cholecystitis, simultaneous cholecystectomy is justified and does not lead to a significant increase in the number of complications. In the case of asymptomatic gallstones, the optimal tactics remains controversial, both a surgical treatment and observation are possible. In the absence of gallstone disease, all patients after the surgical correction of the excess weight are prescribed ursodeoxycholic acid, while performing preventive cholecystectomy is not recommended. A simultaneous ventral hernia repair is justified only for small defects (< 10 cm) of the anterior abdominal wall. If a paraesophageal hernia is detected in patients with morbid obesity, bariatric surgery may be combined with cruroraphy.

About the authors

Alexander V. Smirnov

Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies FMBA of Russia

Author for correspondence.
Email: alvsmirnov@mail.ru
ORCID iD: 0000-0003-3897-8306
SPIN-code: 5619-1151

MD, PhD

Russian Federation, Moscow

Vladimir R. Stankevich

Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies FMBA of Russia

Email: v-stankevich@yandex.ru
ORCID iD: 0000-0002-8620-8755

MD

Russian Federation, Moscow

Dmitriy N. Panchenkov Panchenkov

Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies FMBA of Russia; Moscow State University of Medicine and Dentistry named after A.I. Evdokimov

Email: dnpanchenkov@mail.ru
ORCID iD: 0000-0001-8539-4392

MD, PhD, Professor

Russian Federation, Moscow

Valentin I. Sharobaro

Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies FMBA of Russia

Email: sharobarovi@mail.ru
ORCID iD: 0000-0002-1510-9047
SPIN-code: 3677-0208

MD, PhD, Professor

Russian Federation, Moscow

Yuri V. Ivanov

Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies FMBA of Russia; Moscow State University of Medicine and Dentistry named after A.I. Evdokimov

Email: ivanovkb83@yandex.ru
ORCID iD: 0000-0001-6209-4194
SPIN-code: 3240-4335

MD, PhD, Professor

Russian Federation, Moscow

Yevgeny A. Velichko

Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies FMBA of Russia

Email: velichko_eugen@mail.ru
ORCID iD: 0000-0002-0297-8155
SPIN-code: 9817-2850

MD, PhD

Russian Federation, Moscow

References

  1. Галимов О.В., Федоров А.В., Ханов В.О., Колыгин А.В.К вопросу о целесообразности выполнения сочетанных лапароскопических операций // Эндоскопическая хирургия. —2018. — Т.24. — №4. — С. 3–6. [Galimov OV, Fedorov AV, Khanov VO, Kolygin AV. On the issue of applicability of simultaneous laparoscopic surgeries. Ehndoskopicheskaia khirurgiia. 2018;24(4):3–6. (In Russ).] doi: 10.17116/endoskop2018240413.
  2. Zhang S, Ikramuddin S, Beckwith HC, et al.The impact of bariatric surgery on breast cancer recurrence: case series and review of literature. Obes Surg. 2020;30(2):780–785. doi: 10.1007/s11695-019-04099-6.
  3. Hidalgo JE, Roy M, Ramirez A, et al. Laparoscopic sleeve gastrectomy: a first step for rapid weight loss in morbidly obese patients requiring a second non-bariatric procedure. Obes Surg. 2012;22(4):555–559. doi: 10.1007/s11695-011-0574-z.
  4. Dittrick GW, Thompson JS, Campos D, et al. Gallbladder pathology in morbid obesity. Obes Surg. 2005;15(2):238–242. doi: 10.1381/0960892053268273.
  5. Amstutz S, Michel JM, Kopp S, Egger B. Potential benefits of prophylactic cholecystectomy in patients undergoing bariatric bypass surgery. Obes Surg. 2015;25(11):2054–2060. doi: 10.1007/s11695-015-1650-6.
  6. Csendes A, Csendes P, Orellana O, et al. Patients remain at high risk of gallstones development late (10 y) after sleeve gastrectomy? Surg Laparosc Endosc Percutan Tech. 2019;29(6):451–455. doi: 10.1097/SLE.0000000000000700.
  7. Altieri MS, Yang J, Nie L, et al. Incidence of cholecystectomy after bariatric surgery. Surg Obes Relat Dis. 2018;14(7):992–996. doi: 10.1016/j.soard.2018.03.028.
  8. Gustafsson U, Benthin L, Granström L, et al. Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery. Hepatology. 2005;41(6):1322–1328. doi: 10.1002/hep.20686.
  9. Festi D, Villanova N, Colecchia A. Risk factors for gallstone formation during weight loss. Clin Gastroenterol Hepatol. 2015;13(3):613. doi: 10.1016/j.cgh.2014.08.010.
  10. Alimoğulları M, Buluş H. Predictive factors of gallstone formation after sleeve gastrectomy: a multivariate analysis of risk factors. Surg Today. 2020;50(9):1002–1007. doi: 10.1007/s00595-020-01971-2.
  11. Wanjura V, Szabo E, Österberg J,et al. Morbidity of cholecystectomy and gastric bypass in a national database. Br J Surg. 2018;105(1):121–127. doi: 10.1002/bjs.10666.
  12. Somasekar K, Chan DS, Sreekumar NS, Anwer S. Choledocholithiasis after bariatric surgery-more than a stone’s throw to reach? J Gastrointest Surg. 2018;22(3):529–537. doi: 10.1007/s11605-017-3634-4.
  13. Worni M, Guller U, Shah A,et al. Cholecystectomy concomitant with laparoscopic gastric bypass: a trend analysis of the nationwide inpatient sample from 2001 to 2008. Obes Surg. 2012;22(2):220–229. doi: 10.1007/s11695-011-0575-y.
  14. Doulamis IP, Michalopoulos G, Boikou V, et al. Concomitant cholecystectomy during bariatric surgery: the jury is still out. Am J Surg. 2019;218(2):401–410. doi: 10.1016/j.amjsurg.2019.02.006.
  15. Fuller W, Rasmussen JJ, Ghosh J, Ali MR. Is routine cholecystectomy indicated for asymptomatic cholelithiasis in patients undergoing gastric bypass? Obes Surg. 2007;17(6):747–751. doi: 10.1007/s11695-007-9138-9147.
  16. Tarantino I, Warschkow R, Steffen T, et al. Is routine cholecystectomy justified in severely obese patients undergoing a laparoscopic Roux-en-Y gastric bypass procedure? A comparative cohort study. Obes Surg. 2011;21(12):1870–1878. doi: 10.1007/s11695-011-0495-x.
  17. Caruana JA, McCabe MN, Smith AD,et al. Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary? Surg Obes Relat Dis. 2005;1(6):564–568. doi: 10.1016/j.soard.2005.08.004.
  18. Coupaye M, Castel B, Sami O,et al. Comparison of the incidence of cholelithiasis after sleeve gastrectomy and Roux-en-Y gastric bypass in obese patients: a prospective study. Surg Obes Relat Dis. 2015;11(4):779–784. doi: 10.1016/j.soard.2014.10.015.
  19. D’Hondt M, Sergeant G, Deylgat B, et al. Prophylactic cholecystectomy, a mandatory step in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass? J Gastrointest Surg. 2011;15(9):1532–1536. doi: 10.1007/s11605-011-1617-4.
  20. Hamad GG, Ikramuddin S, Gourash WF, Schauer PR. Elective cholecystectomy during laparoscopic Roux-en-Y gastric bypass: is it worth the wait? Obes Surg. 2003;13(1):76–81. doi: 10.1381/096089203321136638.
  21. Karadeniz M, Görgün M, Kara C. The evaluation of gallstone formation in patients undergoing Roux-en-Y gastric bypass due to morbid obesity. Ulus Cerrahi Derg. 2014;30(2):76–79. doi: 10.5152/UCD.2014.2538.
  22. Kim JJ, Schirmer B. Safety and efficacy of simultaneous cholecystectomy at Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2009;5(1):48–53. doi: 10.1016/j.soard.2008.06.001.
  23. Portenier DD, Grant JP, Blackwood HS, et al. Expectant management of the asymptomatic gallbladder at Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3(4):476–479. doi: 10.1016/j.soard.2007.02.006.
  24. Scott DJ, Villegas L, Sims TL,et al. Intraoperative ultrasound and prophylactic ursodiol for gallstone prevention following laparoscopic gastric bypass. Surg Endosc. 2003;17(11):1796–1802. doi: 10.1007/s00464-002-8930-7.
  25. Taylor J, Leitman IM, Horowitz M. Is routine cholecystectomy necessary at the time of Roux-en-Y gastric bypass? Obes Surg. 2006; 16(6):759–761. doi: 10.1381/096089206777346781.
  26. Tucker ON, Fajnwaks P, Szomstein S, Rosenthal RJ. Is concomitant cholecystectomy necessary in obese patients undergoing laparoscopic gastric bypass surgery? Surg Endosc. 2008;22(11):2450–2454. doi: 10.1007/s00464-008-9769-3.
  27. Villegas L, Schneider B, Provost D, et al. Is routine cholecystectomy required during laparoscopic gastric bypass? Obes Surg. 2004;14(2):206–211. doi: 10.1381/096089204322857573.
  28. Moon RC, Teixeira AF, DuCoin C, et al. Comparison of cholecystectomy cases after Roux-en-Y gastric bypass, sleeve gastrectomy, and gastric banding. Surg Obes Relat Dis. 2014;10(1):64–68. doi: 10.1016/j.soard.2013.04.019.
  29. Lee JH, Han G, Kim YJ, et al. A technique for simultaneous cholecystectomy during bariatric surgery.JSLS. 2015;19(4):e2015.00072. doi: 10.4293/JSLS.2015.00072.
  30. Raziel A, Sakran N, Szold A, Goitein D. Concomitant cholecystectomy during laparoscopic sleeve gastrectomy. Surg Endosc. 2015;29(9):2789–2793. doi: 10.1007/s00464-014-4010-z.
  31. Sioka E, Zacharoulis D, Zachari E, et al. Complicated gallstones after laparoscopic sleeve gastrectomy. J Obes. 2014; 2014:468203. doi: 10.1155/2014/468203.
  32. Clapp B, Lee I, Liggett E, et al. Are Concomitant operations during bariatric surgery safe? An analysis of the MBSAQIP database. Obes Surg. 2020;30(11):4474–4481. doi: 10.1007/s11695-020-04848-y.
  33. Weiss AC, Inui T, Parina R, et al. Concomitant cholecystectomy should be routinely performed with laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2015;29(11):3106–3111. doi: 10.1007/s00464-014-4033-5.
  34. Dorman RB, Zhong W, Abraham AA, et al. Does concomitant cholecystectomy at time of Roux-en-Y gastric bypass impact adverse operative outcomes? Obes Surg. 2013;23(11):1718–1726. doi: 10.1007/s11695-013-1001-4.
  35. Dakour-Aridi HN, El-Rayess HM, Abou-Abbass H, et al. Safety of concomitant cholecystectomy at the time of laparoscopic sleeve gastrectomy: analysis of the American College of Surgeons National Surgical Quality Improvement Program database. Surg Obes Relat Dis. 2017;13(6):934–941. doi: 10.1016/j.soard.2016.12.012.
  36. Sakran N, Dar R, Assalia A, et al. The use of Ursolit for gallstone prophylaxis following bariatric surgery: a randomized-controlled trial. Updates Surg. 2020;72(4):1125–1133. doi: 10.1007/s13304-020-00850-2.
  37. Pizza F, D’Antonio D, Lucido FS, et al. The Role of Ursodeoxycholic Acid (UDCA) in Cholelithiasis Management аfter One Anastomosis Gastric Bypass (OAGB) for Morbid Obesity: results of a monocentric randomized controlled trial. Obes Surg. 2020;30(11):4315–4324. doi: 10.1007/s11695-020-04801-z.
  38. Vural A, Goksu K, Kahraman AN, et al. Increased gallstone formation after sleeve gastrectomy and the preventive role of ursodeoxycholic acid. Acta Gastroenterol Belg. 2020;83(1):33–38.
  39. Şen O, Türkçapar AG, Yerdel MA. Cholelithiasis after sleeve gastrectomy and effectiveness of ursodeoxycholic acid treatment. J Laparoendosc Adv Surg Tech A. 2020;30(11):1150–1152. doi: 10.1089/lap.2020.0077.
  40. Talha A, Abdelbaki T, Farouk A, et al. Cholelithiasis after bariatric surgery, incidence, and prophylaxis: randomized controlled trial. Surg Endosc. 2020;34(12):5331–5337. doi: 10.1007/s00464-019-07323-7.
  41. Coupaye M, Calabrese D, Sami O, et al. Effectiveness of ursodeoxycholic acid in the prevention of cholelithiasis after sleeve gastrectomy. Obes Surg. 2019;29(8):2464–2469. doi: 10.1007/s11695-019-03862-z.
  42. Machado FH, Castro Filho HF, Babadopulos RF, et al. Ursodeoxycholic acid in the prevention of gallstones in patients subjected to Roux-en-Y gastric bypass1. Acta Cir Bras. 2019;34(1):e20190010000009. doi: 10.1590/s0102-865020190010000009.
  43. Coupaye M, Calabrese D, Sami O, et al. Evaluation of incidence of cholelithiasis after bariatric surgery in subjects treated or not treated with ursodeoxycholic acid. Surg Obes Relat Dis. 2017;13(4):681–685. doi: 10.1016/j.soard.2016.11.022.
  44. Abdallah E, Emile SH, Elfeki H,et al. Role of ursodeoxycholic acid in the prevention of gallstone formation after laparoscopic sleeve gastrectomy. Surg Today. 2017;47(7):844–850. doi: 10.1007/s00595-016-1446-x.
  45. Adams LB, Chang C, Pope J,et al. Randomized, prospective comparison of ursodeoxycholic acid for the prevention of gallstones after sleeve gastrectomy. Obes Surg. 2016;26(5):990–994. doi: 10.1007/s11695-015-1858-5.
  46. Miller K, Hell E, Lang B, Lengauer E. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial. Ann Surg. 2003; 238(5):697–702. doi: 10.1097/01.sla.0000094305.77843.
  47. Sugerman HJ, Brewer WH, Shiffman ML, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169(1):91–96. doi: 10.1016/s0002-9610(99)80115-9.
  48. Williams C, Gowan R, Perey BJ. A double-blind placebo-controlled trial of ursodeoxycholic acid in the prevention of gallstones during weight loss after vertical banded gastroplasty. Obes Surg. 1993;3(3):257–259. doi: 10.1381/096089293765559278.
  49. Pineda O, Maydón HG, Amado M, et al.A Prospective study of the conservative management of asymptomatic preoperative and postoperative gallbladder disease in bariatric surgery. Obes Surg. 2017; 27(1):148–153. doi: 10.1007/s11695-016-2264-3.
  50. Della Penna A, Lange J, Hilbert J, et al. Ursodeoxycholic Acid for 6 months after bariatric surgery is impacting gallstone associated morbidity in patients with preoperative asymptomatic gallstones. Obes Surg. 2019;29(4):1216–1221. doi: 10.1007/s11695-018-03651-0.
  51. Regner JL, Mrdutt MM, Munoz-Maldonado Y. Tailoring surgical approach for elective ventral hernia repair based on obesity and National Surgical Quality Improvement Program outcomes. Am J Surg. 2015;210(6):1024–1030. doi: 10.1016/j.amjsurg.2015.08.001.
  52. Eid GM, Mattar SG, Hamad G, et al. Repair of ventral hernias in morbidly obese patients undergoing laparoscopic gastric bypass should not be deferred. Surg Endosc. 2004;18(2):207–210. doi: 10.1007/s00464-003-8915-1.
  53. Spaniolas K, Kasten KR, Mozer AB, et al. Synchronous ventral hernia repair in patients undergoing bariatric surgery. Obes Surg. 2015;25(10):1864–1868. doi: 10.1007/s11695-015-1625-7.
  54. Menzo EL, Hinojosa M, Carbonell A, et al. American Society for Metabolic and Bariatric Surgery and American Hernia Society consensus guideline on bariatric surgery and hernia surgery. Surg Obes Relat Dis. 2018;14(9):1221–1232. doi: 10.1016/j.soard.2018.07.005.
  55. Ashrafi D, Osland E, Memon MA. Bariatric surgery and gastroesophageal reflux disease. Ann Transl Med. 2020; 8(Suppl 1):S11. doi: 10.21037/atm.2019.09.15.
  56. Bakhos CT, Patel SP, Petrov RV, Abbas AE. Management of paraesophageal hernia in the morbidly obese patient. Thorac Surg Clin. 2019;29(4):379–386. doi: 10.1016/j.thorsurg.2019.07.003.
  57. Suter M. Gastroesophageal reflux disease, obesity, and Roux-en-Y gastric bypass: complex relationship-a narrative review. Obes Surg. 2020;30(8):3178–3187. doi: 10.1007/s11695-020-04690-2.
  58. Shada AL, Stem M, Funk LM, et al. Concurrent bariatric surgery and paraesophageal hernia repair: comparison of sleeve gastrectomy and Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2018;14(1):8–13. doi: 10.1016/j.soard.2017.07.026.
  59. Garg H, Vigneshwaran B, Aggarwal S, Ahuja V. Impact of concomitant laparoscopic sleeve gastrectomy and hiatal hernia repair on gastro-oesophageal reflux disease in morbidly obese patients. J Minim Access Surg. 2017;13(2):103–108. doi: 10.4103/0972-9941.201730.
  60. Davis M, Rodriguez J, El-Hayek K, et al. Paraesophagealhernia repair with partial longitudinal gastrectomy in obese patients. JSLS. 2015;19(3):e2015.00060. doi: 10.4293/JSLS.2015.00060.
  61. Nocca D, Mehdi Skalli El, Boulay E, et al. Nissen Sleeve (N-Sleeve) operation: preliminary results of a pilot study. Surg Obes Relat Dis. 2016;12(10):1832–1837.doi: 10.1016/j.soard.2016.02.010.

Copyright (c) 2020 Smirnov A.V., Stankevich V.R., Panchenkov D.N., Sharobaro V.I., Ivanov Y.V., Velichko Y.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies